Postmastectomy Reconstruction in Male Breast Cancer

Table 1

Patient demographics and cancer characteristics.

Author, year	Study type	Country	Patients (n)^a	Age (yrs)	Breast CA type; stage	Tumor size	Hormone receptor	Medical therapy
Al-Kalla and Komorowska-Timek, 2014 [25]	Case report	USA	1	68	IDC; stage 1	1 × 2 cm	ER^+/PR^+	Not reported
Bamba et al., 2017 [26]	Case report	USA	1	78	IDC	Not reported	Not reported	Not reported
Banys-Paluchowski et al., 2016 [1]	Case report	Germany	1	62	Papillary CA; stage 2	16 cm diameter	ER^+/PR^+	Not reported
Danino et al., 1998 [27]	Case report	France	1	57	Stage 4	Not reported	Not reported	Not reported
Di Benedetto et al., 1997 [28]	Retrospective cohort	Italy	11	64 + 6.7	IDC; early: 2 intermediate: 6 advanced: 2	Not reported	Not reported	Not reported
Elshafiey et al., 2011 [29]	Retrospective cohort	Egypt	8 (25%)	Not specified^b	IDC	Not reported	Not specified^b	Not reported
Giunta et al., 2017 [30]	Case report	Italy	1	46	IDC; stage 1	Not reported	ER^+/PR^+	None
Igun, 2000 [31]	Case report	Nigeria	1	35	IDC; stage 3	3 × 3 cm	Not reported	Adjuvant tamoxifen, chemotherapy
Nakao et al., 2002 [32]	Case report	Japan	1	59	IDC; stage 4	9 × 6 cm	Not reported	Neoadjuvant chemotherapy
Schaverien et al., 2013 [33]	Case report	Scotland	2	35, 59	IDC; stage 2, stage 1	3 × 2 cm 1 × 1 cm	ER^+/PR^−ER^+/PR+	Adjuvant tamoxifen, chemotherapy, XRT
Spear et al., 1997 [34]	Case report	USA	1	49	IDC, stage 2	2.2 cm	ER^+/PR^+	None

Age is presented as n or mean ± standard deviation. ^aNumber of patients who underwent postmastectomy reconstruction. ^bNot specified for the 8 patients who underwent postmastectomy reconstruction. CA: carcinoma; IDC: invasive ductal carcinoma; MRM: modified radical mastectomy; XRT: radiation therapy.